DOXGX | JVLCX | DOXGX / JVLCX | |
Total Expense Ratio | 0.41 | 1.71 | 24% |
Annual Report Gross Expense Ratio | 0.46 | 1.72 | 27% |
Fund Existence | 3 years | 17 years | - |
Gain YTD | 7.699 | 7.822 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 18.1B | 630% |
Annual Yield % from dividends | 1.47 | 0.02 | 6,795% |
Returns for 1 year | 8.43 | -1.26 | -667% |
Returns for 3 years | 32.25 | 14.19 | 227% |
Returns for 5 years | N/A | 39.89 | - |
Returns for 10 years | N/A | 26.32 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ROBT | 49.17 | 0.70 | +1.44% |
FT Nasdaq Artfcl Intllgnc and Rbtc ETF | |||
INRO | 29.33 | 0.30 | +1.04% |
iShares U.S. Industry Rotation Act ETF | |||
IHI | 62.30 | 0.14 | +0.23% |
iShares US Medical Devices ETF | |||
ABNY | 11.74 | 0.01 | +0.11% |
YieldMax ABNB Option Income Strategy ETF | |||
BSJU | 26.02 | N/A | N/A |
Invesco BulletShares 2030 HY Corp Bd ETF |